BACKGROUND: Endoscopic lung volume reduction (ELVR) with valves is a treatment option for selected patients with emphysema. Collateral Ventilation (CV) is measured directly with the Chartis(®) bronchoscopic assessment system (PulmonX Inc. Redwood City, CA, USA) and indirectly via fissure completeness score (FCS) on computed-tomography (CT). It remains unclear, whether the additional Chartis(®) assessment improves treatment outcome when the target lobe shows intact fissure (FCS
- Saccomanno, J.
- Sgarbossa, T.
- Neumann, K.
- Stanzel, F.
- Andreas, S.
- Eisenmann, S.
- Schmidt, B.
- Gesierich, W.
- Witzenrath, M.
- Hübner, R. H.
Keywords
- Humans
- Retrospective Studies
- *Pulmonary Emphysema/physiopathology/surgery/diagnostic imaging/diagnosis
- Male
- Female
- Germany
- Treatment Outcome
- *Lung/physiopathology/diagnostic imaging/surgery
- Aged
- Middle Aged
- Registries
- *Pneumonectomy/adverse effects/methods/instrumentation
- *Bronchoscopy/adverse effects
- Predictive Value of Tests
- Time Factors
- Exercise Tolerance
- Recovery of Function
- *Pulmonary Ventilation
- *Tomography, X-Ray Computed
- *Software
- Quality of Life
- Copd
- Lung emphysema
- collateral ventilation
- endoscopic lung volume reduction with valves
